Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹82 Cr₹184 Cr₹622 Cr₹1,660 Cr₹2,972 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹82 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr
Mar2021₹1,660 Cr
Mar2020₹2,972 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr
-62.55
Mar2021 ₹1,660 Cr
-44.15
Mar2020 ₹2,972 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹117,760.2 Cr 3.3% -4.8% 6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,744.0 Cr -4.2% -7.7% 24.1% Stock Analytics
DIVIS LABORATORIES ₹152,209.0 Cr -0.6% -5.6% 57.5% Stock Analytics
MANKIND PHARMA ₹102,663.0 Cr -0.7% -13.8% 18.2% Stock Analytics
DR REDDYS LABORATORIES ₹99,705.3 Cr -2.4% -12.8% 1.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,929.3 Cr -0.3% -2.1% 24.5% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

3.3%

-4.8%

6.5%

SENSEX

0.3%

-1.8%

8.6%


You may also like the below Video Courses